Viyash Scientific Ltd (VIYASH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Part of MojoOne Strategy

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Corona Remedies

Bliss GVS Pharma

Viyash Scientifi

Akums Drugs

Aarti Pharma

Strides Pharma

Sudeep Pharma

Sanofi India

P & G Health Ltd

Sanofi Consumer

Blue Jet Health

Why is Viyash Scientific Ltd ?

Poor Management Efficiency with a low ROE of 4.59%

The company has been able to generate a Return on Equity (avg) of 4.59% signifying low profitability per unit of shareholders funds

Low ability to service debt as the company has a high Debt to EBITDA ratio of 0.75 times

Low ability to service debt as the company has a high Debt to EBITDA ratio of 0.75 times
The company has been able to generate a Return on Equity (avg) of 4.59% signifying low profitability per unit of shareholders funds

Healthy long term growth as Net Sales has grown by an annual rate of 20.85% and Operating profit at 28.24%

With a growth in Net Profit of 115.17%, the company declared Very Positive results in Jun 26

The company has declared positive results for the last 10 consecutive quarters
OPERATING PROFIT TO INTEREST(Q) Highest at 14.26 times
PBT LESS OI(Q) At Rs 104.10 cr has Grown at 143.51%
DEBT-EQUITY RATIO(HY) Lowest at 0.17 times

With ROE of 7.1, it has a Fair valuation with a 3.8 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 25.64%, its profits have risen by 150.3% ; the PEG ratio of the company is 1.1

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Viyash Scientifi should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Viyash Scientifi for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Viyash Scientifi

25.64%

0.60

42.72%

Sensex

-10.5%

-0.78

13.50%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.85%

EBIT Growth (5y)

28.24%

EBIT to Interest (avg)

2.30

Debt to EBITDA (avg)

9.68

Net Debt to Equity (avg)

0.08

Sales to Capital Employed (avg)

1.37

Tax Ratio

35.34%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.26%

ROCE (avg)

6.09%

ROE (avg)

4.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.78

EV to EBIT

23.81

EV to EBITDA

15.78

EV to Capital Employed

3.59

EV to Sales

3.14

PEG Ratio

1.09

Dividend Yield

ROCE (Latest)

13.36%

ROE (Latest)

7.11%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company

OPERATING PROFIT TO INTEREST(Q)

Highest at 14.26 times

PBT LESS OI(Q)

At Rs 104.10 cr has Grown at 143.51%

DEBT-EQUITY RATIO(HY)

Lowest at 0.17 times

NET SALES(Q)

Highest at Rs 946.36 cr

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 269.71 cr

PAT(Q)

Highest at Rs 65.87 cr.

-2What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.27 times

Loading Valuation Snapshot...

Here's what is working for Viyash Scientifi

Operating Profit to Interest - Quarterly

Highest at 14.26 times and Grown

each quarter in the last five quarters

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 104.10 cr has Grown at 143.51%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 65.87 cr has Grown at 101.1%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 946.36 cr and Grown

each quarter in the last five quarters

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly

Lowest at 0.17 times and Fallen

each half year in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Profit After Tax (PAT) - Quarterly

Highest at Rs 65.87 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly

Highest at Rs 269.71 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Viyash Scientifi

Debtors Turnover Ratio- Half Yearly

Lowest at 3.27 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio